FDA Import Refusal 112-7011726-4/1/1 — Novartis Pharmaceuticals Canada Inc.
The FDA refused shipment 112-7011726-4/1/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on Jun 8, 2012. The refused product falls under Drugs and Biologics — CLOZAPINE (SEDATIVE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 8, 2012
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 65VCC13 CLOZAPINE (SEDATIVE)
- Charges
- 75